Table of Content

1 Neurotensin Market Overview
1.1 Product Overview and Scope of Neurotensin
1.2 Neurotensin Segment by Type
1.2.1 Global Neurotensin Market Value Comparison by Type (2024-2034)
1.2.2 Human
1.2.3 Bovine
1.2.4 Canine
1.2.5 Mouse
1.3 Neurotensin Segment by Application
1.3.1 Global Neurotensin Market Value by Application: (2024-2034)
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Others
1.4 Global Neurotensin Market Size Estimates and Forecasts
1.4.1 Global Neurotensin Revenue 2018-2034
1.4.2 Global Neurotensin Sales 2018-2034
1.4.3 Global Neurotensin Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Neurotensin Market Competition by Manufacturers
2.1 Global Neurotensin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Neurotensin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Neurotensin Average Price by Manufacturers (2018-2023)
2.4 Global Neurotensin Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Neurotensin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurotensin, Product Type & Application
2.7 Neurotensin Market Competitive Situation and Trends
2.7.1 Neurotensin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurotensin Players Market Share by Revenue
2.7.3 Global Neurotensin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurotensin Retrospective Market Scenario by Region
3.1 Global Neurotensin Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Neurotensin Global Neurotensin Sales by Region: 2018-2034
3.2.1 Global Neurotensin Sales by Region: 2018-2023
3.2.2 Global Neurotensin Sales by Region: 2024-2034
3.3 Global Neurotensin Global Neurotensin Revenue by Region: 2018-2034
3.3.1 Global Neurotensin Revenue by Region: 2018-2023
3.3.2 Global Neurotensin Revenue by Region: 2024-2034
3.4 North America Neurotensin Market Facts & Figures by Country
3.4.1 North America Neurotensin Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Neurotensin Sales by Country (2018-2034)
3.4.3 North America Neurotensin Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neurotensin Market Facts & Figures by Country
3.5.1 Europe Neurotensin Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Neurotensin Sales by Country (2018-2034)
3.5.3 Europe Neurotensin Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurotensin Market Facts & Figures by Country
3.6.1 Asia Pacific Neurotensin Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Neurotensin Sales by Country (2018-2034)
3.6.3 Asia Pacific Neurotensin Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neurotensin Market Facts & Figures by Country
3.7.1 Latin America Neurotensin Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Neurotensin Sales by Country (2018-2034)
3.7.3 Latin America Neurotensin Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurotensin Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurotensin Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Neurotensin Sales by Country (2018-2034)
3.8.3 Middle East and Africa Neurotensin Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Neurotensin Sales by Type (2018-2034)
4.1.1 Global Neurotensin Sales by Type (2018-2023)
4.1.2 Global Neurotensin Sales by Type (2024-2034)
4.1.3 Global Neurotensin Sales Market Share by Type (2018-2034)
4.2 Global Neurotensin Revenue by Type (2018-2034)
4.2.1 Global Neurotensin Revenue by Type (2018-2023)
4.2.2 Global Neurotensin Revenue by Type (2024-2034)
4.2.3 Global Neurotensin Revenue Market Share by Type (2018-2034)
4.3 Global Neurotensin Price by Type (2018-2034)
5 Segment by Application
5.1 Global Neurotensin Sales by Application (2018-2034)
5.1.1 Global Neurotensin Sales by Application (2018-2023)
5.1.2 Global Neurotensin Sales by Application (2024-2034)
5.1.3 Global Neurotensin Sales Market Share by Application (2018-2034)
5.2 Global Neurotensin Revenue by Application (2018-2034)
5.2.1 Global Neurotensin Revenue by Application (2018-2023)
5.2.2 Global Neurotensin Revenue by Application (2024-2034)
5.2.3 Global Neurotensin Revenue Market Share by Application (2018-2034)
5.3 Global Neurotensin Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Peptide Institute
6.1.1 Peptide Institute Corporation Information
6.1.2 Peptide Institute Description and Business Overview
6.1.3 Peptide Institute Neurotensin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Peptide Institute Neurotensin Product Portfolio
6.1.5 Peptide Institute Recent Developments/Updates
6.2 Genscript
6.2.1 Genscript Corporation Information
6.2.2 Genscript Description and Business Overview
6.2.3 Genscript Neurotensin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Genscript Neurotensin Product Portfolio
6.2.5 Genscript Recent Developments/Updates
6.3 Bio - Techne
6.3.1 Bio - Techne Corporation Information
6.3.2 Bio - Techne Description and Business Overview
6.3.3 Bio - Techne Neurotensin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bio - Techne Neurotensin Product Portfolio
6.3.5 Bio - Techne Recent Developments/Updates
6.4 MedChemExpress
6.4.1 MedChemExpress Corporation Information
6.4.2 MedChemExpress Description and Business Overview
6.4.3 MedChemExpress Neurotensin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 MedChemExpress Neurotensin Product Portfolio
6.4.5 MedChemExpress Recent Developments/Updates
6.5 PerkinElmer
6.5.1 PerkinElmer Corporation Information
6.5.2 PerkinElmer Description and Business Overview
6.5.3 PerkinElmer Neurotensin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 PerkinElmer Neurotensin Product Portfolio
6.5.5 PerkinElmer Recent Developments/Updates
6.6 APExBIO
6.6.1 APExBIO Corporation Information
6.6.2 APExBIO Description and Business Overview
6.6.3 APExBIO Neurotensin Sales, Revenue and Gross Margin (2018-2023)
6.6.4 APExBIO Neurotensin Product Portfolio
6.6.5 APExBIO Recent Developments/Updates
6.7 Eurogentec
6.6.1 Eurogentec Corporation Information
6.6.2 Eurogentec Description and Business Overview
6.6.3 Eurogentec Neurotensin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Eurogentec Neurotensin Product Portfolio
6.7.5 Eurogentec Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurotensin Industry Chain Analysis
7.2 Neurotensin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurotensin Production Mode & Process
7.4 Neurotensin Sales and Marketing
7.4.1 Neurotensin Sales Channels
7.4.2 Neurotensin Distributors
7.5 Neurotensin Customers
8 Neurotensin Market Dynamics
8.1 Neurotensin Industry Trends
8.2 Neurotensin Market Drivers
8.3 Neurotensin Market Challenges
8.4 Neurotensin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Neurotensin Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Neurotensin Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Neurotensin Market Competitive Situation by Manufacturers in 2024
Table 4. Global Neurotensin Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Neurotensin Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Neurotensin Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Neurotensin Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Neurotensin Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Neurotensin, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Neurotensin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neurotensin, Product Type & Application
Table 12. Global Key Manufacturers of Neurotensin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neurotensin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurotensin as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neurotensin Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Neurotensin Sales by Region (2018-2023) & (K Units)
Table 18. Global Neurotensin Sales Market Share by Region (2018-2023)
Table 19. Global Neurotensin Sales by Region (2024-2034) & (K Units)
Table 20. Global Neurotensin Sales Market Share by Region (2024-2034)
Table 21. Global Neurotensin Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Neurotensin Revenue Market Share by Region (2018-2023)
Table 23. Global Neurotensin Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Neurotensin Revenue Market Share by Region (2024-2034)
Table 25. North America Neurotensin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Neurotensin Sales by Country (2018-2023) & (K Units)
Table 27. North America Neurotensin Sales by Country (2024-2034) & (K Units)
Table 28. North America Neurotensin Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Neurotensin Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Neurotensin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Neurotensin Sales by Country (2018-2023) & (K Units)
Table 32. Europe Neurotensin Sales by Country (2024-2034) & (K Units)
Table 33. Europe Neurotensin Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Neurotensin Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Neurotensin Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Neurotensin Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Neurotensin Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Neurotensin Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Neurotensin Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Neurotensin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Neurotensin Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Neurotensin Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Neurotensin Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Neurotensin Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Neurotensin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Neurotensin Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Neurotensin Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Neurotensin Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Neurotensin Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Neurotensin Sales (K Units) by Type (2018-2023)
Table 51. Global Neurotensin Sales (K Units) by Type (2024-2034)
Table 52. Global Neurotensin Sales Market Share by Type (2018-2023)
Table 53. Global Neurotensin Sales Market Share by Type (2024-2034)
Table 54. Global Neurotensin Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Neurotensin Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Neurotensin Revenue Market Share by Type (2018-2023)
Table 57. Global Neurotensin Revenue Market Share by Type (2024-2034)
Table 58. Global Neurotensin Price (US$/Unit) by Type (2018-2023)
Table 59. Global Neurotensin Price (US$/Unit) by Type (2024-2034)
Table 60. Global Neurotensin Sales (K Units) by Application (2018-2023)
Table 61. Global Neurotensin Sales (K Units) by Application (2024-2034)
Table 62. Global Neurotensin Sales Market Share by Application (2018-2023)
Table 63. Global Neurotensin Sales Market Share by Application (2024-2034)
Table 64. Global Neurotensin Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Neurotensin Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Neurotensin Revenue Market Share by Application (2018-2023)
Table 67. Global Neurotensin Revenue Market Share by Application (2024-2034)
Table 68. Global Neurotensin Price (US$/Unit) by Application (2018-2023)
Table 69. Global Neurotensin Price (US$/Unit) by Application (2024-2034)
Table 70. Peptide Institute Corporation Information
Table 71. Peptide Institute Description and Business Overview
Table 72. Peptide Institute Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Peptide Institute Neurotensin Product
Table 74. Peptide Institute Recent Developments/Updates
Table 75. Genscript Corporation Information
Table 76. Genscript Description and Business Overview
Table 77. Genscript Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Genscript Neurotensin Product
Table 79. Genscript Recent Developments/Updates
Table 80. Bio - Techne Corporation Information
Table 81. Bio - Techne Description and Business Overview
Table 82. Bio - Techne Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Bio - Techne Neurotensin Product
Table 84. Bio - Techne Recent Developments/Updates
Table 85. MedChemExpress Corporation Information
Table 86. MedChemExpress Description and Business Overview
Table 87. MedChemExpress Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. MedChemExpress Neurotensin Product
Table 89. MedChemExpress Recent Developments/Updates
Table 90. PerkinElmer Corporation Information
Table 91. PerkinElmer Description and Business Overview
Table 92. PerkinElmer Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. PerkinElmer Neurotensin Product
Table 94. PerkinElmer Recent Developments/Updates
Table 95. APExBIO Corporation Information
Table 96. APExBIO Description and Business Overview
Table 97. APExBIO Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. APExBIO Neurotensin Product
Table 99. APExBIO Recent Developments/Updates
Table 100. Eurogentec Corporation Information
Table 101. Eurogentec Description and Business Overview
Table 102. Eurogentec Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Eurogentec Neurotensin Product
Table 104. Eurogentec Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Neurotensin Distributors List
Table 108. Neurotensin Customers List
Table 109. Neurotensin Market Trends
Table 110. Neurotensin Market Drivers
Table 111. Neurotensin Market Challenges
Table 112. Neurotensin Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neurotensin
Figure 2. Global Neurotensin Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Neurotensin Market Share by Type in 2024 & 2034
Figure 4. Human Product Picture
Figure 5. Bovine Product Picture
Figure 6. Canine Product Picture
Figure 7. Mouse Product Picture
Figure 8. Global Neurotensin Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Neurotensin Market Share by Application in 2024 & 2034
Figure 10. Scientific Research
Figure 11. Medical
Figure 12. Others
Figure 13. Global Neurotensin Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Neurotensin Market Size (2018-2034) & (US$ Million)
Figure 15. Global Neurotensin Sales (2018-2034) & (K Units)
Figure 16. Global Neurotensin Average Price (US$/Unit) & (2018-2034)
Figure 17. Neurotensin Report Years Considered
Figure 18. Neurotensin Sales Share by Manufacturers in 2024
Figure 19. Global Neurotensin Revenue Share by Manufacturers in 2024
Figure 20. The Global 5 and 10 Largest Neurotensin Players: Market Share by Revenue in 2024
Figure 21. Neurotensin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 22. Global Neurotensin Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 23. North America Neurotensin Sales Market Share by Country (2018-2034)
Figure 24. North America Neurotensin Revenue Market Share by Country (2018-2034)
Figure 25. U.S. Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Canada Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Europe Neurotensin Sales Market Share by Country (2018-2034)
Figure 28. Europe Neurotensin Revenue Market Share by Country (2018-2034)
Figure 29. Germany Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. France Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. U.K. Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Italy Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Russia Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Asia Pacific Neurotensin Sales Market Share by Region (2018-2034)
Figure 35. Asia Pacific Neurotensin Revenue Market Share by Region (2018-2034)
Figure 36. China Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Japan Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. South Korea Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. India Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Australia Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Taiwan Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Indonesia Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Thailand Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Malaysia Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Philippines Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Latin America Neurotensin Sales Market Share by Country (2018-2034)
Figure 47. Latin America Neurotensin Revenue Market Share by Country (2018-2034)
Figure 48. Mexico Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Argentina Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Middle East & Africa Neurotensin Sales Market Share by Country (2018-2034)
Figure 52. Middle East & Africa Neurotensin Revenue Market Share by Country (2018-2034)
Figure 53. Turkey Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. U.A.E Neurotensin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Global Sales Market Share of Neurotensin by Type (2018-2034)
Figure 57. Global Revenue Market Share of Neurotensin by Type (2018-2034)
Figure 58. Global Neurotensin Price (US$/Unit) by Type (2018-2034)
Figure 59. Global Sales Market Share of Neurotensin by Application (2018-2034)
Figure 60. Global Revenue Market Share of Neurotensin by Application (2018-2034)
Figure 61. Global Neurotensin Price (US$/Unit) by Application (2018-2034)
Figure 62. Neurotensin Value Chain
Figure 63. Neurotensin Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed